Drug Profile
Ibuprofen/sodium cromoglicate- AZTherapies
Alternative Names: ALZT OP1; ALZT-OP1a + ALZT-OP1b; Ibuprofen + cromolyn; Ibuprofen + sodium cromoglicateLatest Information Update: 22 Apr 2022
Price :
$50
*
At a glance
- Originator AZTherapies
- Class Amines; Analgesics; Antiallergics; Antiasthmatics; Antidementias; Antipyretics; Antirheumatics; Antitussives; Benzopyrans; Chromones; Neuroprotectants; Nonsteroidal anti-inflammatories; Nootropics; Phenylpropionates; Small molecules
- Mechanism of Action Amyloid beta-protein inhibitors; Inflammation mediator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Alzheimer's disease
Most Recent Events
- 22 Apr 2022 Phase-III development is ongoing in the US, Australia, Canada, Bulgaria, Czech Republic, Poland, and Hungary
- 18 Jan 2021 AZTherapies completes a phase I/II trial in Alzheimer's disease in USA (PO) (NCT04570644)
- 13 Nov 2020 AZTherapies completes the phase III COGNITE trial for Alzheimer's disease (Early-stage disease) in USA, Australia, Bulgaria, Canada, Czech Republic, Hungary and Poland (PO) (NCT02547818)